NMC
ADAP
NEA Management Company’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.09M | Hold |
17,079,778
| – | – | 0.31% | 26 |
|
|
2025
Q1 | $3.36M | Hold |
17,079,778
| – | – | 0.26% | 30 |
|
|
2024
Q4 | $9.2M | Hold |
17,079,778
| – | – | 0.52% | 27 |
|
|
2024
Q3 | $16.2M | Hold |
17,079,778
| – | – | 0.88% | 20 |
|
|
2024
Q2 | $16.7M | Hold |
17,079,778
| – | – | 1.25% | 18 |
|
|
2024
Q1 | $27M | Hold |
17,079,778
| – | – | 1.68% | 15 |
|
|
2023
Q4 | $13.5M | Hold |
17,079,778
| – | – | 0.9% | 22 |
|
|
2023
Q3 | $13.3M | Hold |
17,079,778
| – | – | 1.03% | 22 |
|
|
2023
Q2 | $15.8M | Sell |
17,079,778
-1
| -0% | -$1 | 1.21% | 23 |
|
|
2023
Q1 | $18.6M | Hold |
17,079,779
| – | – | 1.29% | 21 |
|
|
2022
Q4 | $24.9M | Sell |
17,079,779
-2,833
| -0% | -$4.14K | 1.4% | 18 |
|
|
2022
Q3 | $18.4M | Hold |
17,082,612
| – | – | 0.92% | 29 |
|
|
2022
Q2 | $29M | Buy |
17,082,612
+1
| +0% | +$2 | 1.49% | 17 |
|
|
2022
Q1 | $35.2M | Hold |
17,082,611
| – | – | 1.02% | 18 |
|
|
2021
Q4 | $64.1M | Hold |
17,082,611
| – | – | 1.29% | 15 |
|
|
2021
Q3 | $88.3M | Hold |
17,082,611
| – | – | 1.05% | 13 |
|
|
2021
Q2 | $72.8M | Hold |
17,082,611
| – | – | 0.95% | 15 |
|
|
2021
Q1 | $90.7M | Hold |
17,082,611
| – | – | 2.04% | 12 |
|
|
2020
Q4 | $92.1M | Hold |
17,082,611
| – | – | 2.43% | 13 |
|
|
2020
Q3 | $136M | Hold |
17,082,611
| – | – | 5.77% | 3 |
|
|
2020
Q2 | $171M | Hold |
17,082,611
| – | – | 6.87% | 4 |
|
|
2020
Q1 | $46.5M | Buy |
17,082,611
+1,250,000
| +8% | +$3.4M | 2.43% | 15 |
|
|
2019
Q4 | $19M | Hold |
15,832,611
| – | – | 0.9% | 19 |
|
|
2019
Q3 | $23.9M | Hold |
15,832,611
| – | – | 1.98% | 15 |
|
|
2019
Q2 | $63.6M | Hold |
15,832,611
| – | – | 4.46% | 7 |
|
|
2019
Q1 | $68.1M | Hold |
15,832,611
| – | – | 3.53% | 10 |
|
|
2018
Q4 | $91M | Hold |
15,832,611
| – | – | 3.61% | 6 |
|
|
2018
Q3 | $215M | Buy |
15,832,611
+2,500,000
| +19% | +$33.9M | 9.26% | 2 |
|
|
2018
Q2 | $158M | Hold |
13,332,611
| – | – | 7.41% | 2 |
|
|
2018
Q1 | $150M | Buy |
13,332,611
+1,306,612
| +11% | +$14.7M | 6.66% | 3 |
|
|
2017
Q4 | $80.3M | Hold |
12,025,999
| – | – | 3.33% | 9 |
|
|
2017
Q3 | $98.5M | Hold |
12,025,999
| – | – | 3.45% | 6 |
|
|
2017
Q2 | $54M | Hold |
12,025,999
| – | – | 1.96% | 10 |
|
|
2017
Q1 | $66.3M | Buy |
12,025,999
+2,145,000
| +22% | +$11.8M | 2.3% | 8 |
|
|
2016
Q4 | $40M | Hold |
9,880,999
| – | – | 1.59% | 13 |
|
|
2016
Q3 | $69.7M | Hold |
9,880,999
| – | – | 3.13% | 6 |
|
|
2016
Q2 | $80.5M | Hold |
9,880,999
| – | – | 4.18% | 6 |
|
|
2016
Q1 | $80.3M | Buy |
+9,880,999
| New | +$80.3M | 5.33% | 4 |
|